Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate. - Wikidata - awgldk - TriplyDB

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.

http://www.wikidata.org/entity/Q34576427

about

The 5-HTTLPR polymorphism of the serotonin transporter gene and short term behavioral response to methylphenidate in children with ADHD ADHD and smoking: from genes to brain to behavior The rare DAT coding variant Val559 perturbs DA neuron function, changes behavior, and alters in vivo responses to psychostimulants.Dopamine transporter gene variation modulates activation of striatum in youth with ADHD Dopamine transporter 3'UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD.Dopamine transporter genotype and stimulant dose-response in youth with attention-deficit/hyperactivity disorder.Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder.Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics.A candidate gene analysis of methylphenidate response in attention-deficit/hyperactivity disorder Epigenetics in Developmental Disorder: ADHD and Endophenotypes Pilot Phase II study of mazindol in children with attention deficit/hyperactivity disorder.Pharmacogenetic treatments for drug addiction: cocaine, amphetamine and methamphetamine.Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.Monoamine transporters: vulnerable and vital doorkeepers.Genetic factors modulating the response to stimulant drugs in humans.Association Between 5-HTTLPR Polymorphism and Tics after Treatment with Methylphenidate in Korean Children with Attention-Deficit/Hyperactivity Disorder.Relation of maternal stress during pregnancy to symptom severity and response to treatment in children with ADHD.DRD4 and DAT1 in ADHD: Functional neurobiology to pharmacogenetics.Interaction of dopamine transporter gene and observed parenting behaviors on attention-deficit/hyperactivity disorder: a structural equation modeling approach The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy.The association of a novel haplotype in the dopamine transporter with preschool age posttraumatic stress disorder.Candidate gene studies of a promising intermediate phenotype: failure to replicate.Rats classified as low or high cocaine locomotor responders: a unique model involving striatal dopamine transporters that predicts cocaine addiction-like behaviors.Human dopamine transporter gene: differential regulation of 18-kb haplotypes A current update on ADHD pharmacogenomics.Integration of pharmacogenetics and pharmacogenomics in drug development: implications for regulatory and medical decision making in pediatric diseases.ADHD pharmacogenetics across the life cycle: New findings and perspectives.Application of Research Domain Criteria to childhood and adolescent impulsive and addictive disorders: Implications for treatment.Meta-analysis of the association between dopamine transporter genotype and response to methylphenidate treatment in ADHD.Potential for diagnosis versus therapy monitoring of attention deficit hyperactivity disorder: a new epigenetic biomarker interacting with both genotype and auto-immunity.SLC6A3 polymorphism and response to methylphenidate in children with ADHD: A systematic review and meta-analysis.Pharmacogenetics of methylphenidate response and tolerability in attention-deficit/hyperactivity disorder.

P2860

Q24288955-CAFB1F75-2DB5-4F5E-A6C7-5AB16DE53A08 Q28300210-D08092F1-FED9-4D52-B6F6-9CE8E4A0B4F4 Q30412810-45C42B50-6810-4792-A65A-DED907226203 Q30495097-AF610B72-ABD6-4578-BB14-71615E0FFC9D Q33344259-DCE3B6AA-BA73-4B9E-BF81-6173C9B6EB1C Q33782844-BB8ABF56-CA99-4852-9AC2-74FE8820DABD Q33799533-DFB4FD15-FDF5-4021-9789-B87FD73326E2 Q33870580-B37B4EEE-6D03-4420-8638-70B9270D99B0 Q33926699-2E62E20C-C5BC-4AA8-8F70-3F44B39AB1B2 Q34030129-74F7907B-C045-46D9-AAD2-BB59AF936A3A Q34700914-4D830E51-5548-4411-86A4-C118490CAF7C Q34982551-F53F0A91-4E2B-4C65-8DAD-D440EA7850FE Q35575795-4E7D8C69-74E4-42DD-BFE5-0CBDA515DCDA Q35877150-3833656C-C2AB-426E-B790-EFFA63739F30 Q36071808-9A8DD6B3-8B70-4D6E-A17E-2A0B93C042C3 Q36191677-968DBE9B-D789-478B-BEF7-B97170E1F6F2 Q36345278-0286FC54-83DB-4162-B3E4-7897CA9A3E69 Q36441473-8A923715-B522-4141-A30B-21826F05F892 Q36652175-174D9A53-9BD5-4EA3-B8F0-79D765AB4513 Q36699910-7B2CA6AD-540C-4EBF-9AC7-0E33BEB5F9D0 Q36853136-327EF00E-AAB3-48E4-8919-4B1D6983A83F Q36901154-449C4266-33A0-461E-9FA9-F2ECC570215A Q37261034-8B15730F-F98F-44D1-83BA-707AF069FDAC Q37408178-7561A8D0-38C0-426D-9B96-B1DF405184C0 Q37710514-9F39FBA4-8B62-4DBD-9E78-A0B5D1C7B134 Q37874869-6AF30B6B-3B25-4B3C-915A-8BF9E0354503 Q38209972-B9D598A1-C5A1-4CAA-86ED-9FBA57907AF5 Q39016970-D03A0C6A-E674-4F75-A68B-9E1CC5337202 Q44596771-184149FD-973F-406D-A026-91A00A070F77 Q47642834-4B602BB2-0D1E-49DA-8716-24146AF91811 Q48241287-D61D8128-4E23-4798-848B-C2717B35909D Q50266015-A7B0EEA6-0F09-4876-AF33-799B2BD732E5

P2860

Dopamine transporter 3'-UTR VNTR genotype and ADHD: a pharmaco-behavioural genetic study with methylphenidate.

http://www.wikidata.org/entity/Q34576427

description

2006 nî lūn-bûn

@nan

2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Dopamine transporter 3'-UTR VN ...... ic study with methylphenidate.

@ast

Dopamine transporter 3'-UTR VN ...... ic study with methylphenidate.

@en

Dopamine transporter 3'-UTR VN ...... ic study with methylphenidate.

@nl

type

label

Dopamine transporter 3'-UTR VN ...... ic study with methylphenidate.

@ast

Dopamine transporter 3'-UTR VN ...... ic study with methylphenidate.

@en

Dopamine transporter 3'-UTR VN ...... ic study with methylphenidate.

@nl

prefLabel

Dopamine transporter 3'-UTR VN ...... ic study with methylphenidate.

@ast

Dopamine transporter 3'-UTR VN ...... ic study with methylphenidate.

@en

Dopamine transporter 3'-UTR VN ...... ic study with methylphenidate.

@nl

P1433

Q34576427-0455E3AB-D1BA-4251-8E98-3C558C617FF9

P1476

Q34576427-B71916F6-0BC2-41B3-8510-26D27CFA2DB9

P2093

Q34576427-1084CA08-20A9-422B-9AA9-0B73D64D51F1

Q34576427-1C87FD9F-2FC3-46A3-842B-F99428C4EBDC

Q34576427-3AB07029-909B-48E0-A89C-C8007FE1C83B

Q34576427-4564DD09-A97B-43F3-BB6E-E0FEFFD26C81

Q34576427-78ADE38A-9C9B-4535-9110-B2B2256A8992

Q34576427-934BE969-1C68-4197-A5D0-4EA3F396623B

Q34576427-A0A4EEB0-E173-4D90-9136-E45836CB6BD1

Q34576427-D3B13068-6F46-47A1-8C3C-9CA093FF199A

Q34576427-DD5ECE69-2ACC-4898-BB7A-46E17CFB812B

Q34576427-DD7D3DD0-8DA4-45B4-8EAA-7B1517A286C8

P2860

Q34576427-069B26CF-9872-445C-AE53-044436DA7605

Q34576427-0787122D-FE67-4439-99B6-77E511814992

Q34576427-0E352747-032E-439E-B6A9-891455AF9AD9

Q34576427-120244A8-857A-4980-A0CE-3E4BB963EAD2

Q34576427-194623D1-5EA5-4014-A321-DB11D0065381

Q34576427-19D1745E-81C8-45FB-88D4-4F769AB1DD5A

Q34576427-1D795CBC-1646-4EC9-9E8E-3EC502696A7B

Q34576427-25FD5417-C9DC-424D-91B4-68E43A7681D1

Q34576427-2F7C29F5-DB58-442E-B719-7B7163B5B9FC

Q34576427-35CD08CC-5AD0-4FA2-A27A-B35C95C28ED5

P2888

Q34576427-445E5712-9F8E-4844-BE68-BCE241C075A6

P304

Q34576427-9461404E-CCF2-4EB9-BFA2-137B4F32EA67

P31

Q34576427-EACEF248-6CFE-4840-A449-CA05DF2CD6AA

P356

Q34576427-34830183-6320-4592-BAF5-87DAA07EF3F5

P407

Q34576427-678236FE-AB28-401A-A9C3-2F9B932CB0D8

P433

Q34576427-C3BD0095-EFE3-45BB-8387-1067B494A6EA

P478

Q34576427-B99570F7-7684-4A64-9728-81075585E2AC

P50

Q34576427-99862E39-50A2-4D8F-8410-990FC2D5A741

P577

Q34576427-7F1C1B80-64D0-4449-81F2-D110AF553E0E

P5875

Q34576427-93E690A6-E69E-43EF-8CCE-47964F7171DA

P6179

Q34576427-AA205D97-8A02-4455-BE85-B898A8D8A638

P698

Q34576427-117798B6-C6BA-4366-97AE-38BFF4E65339

P921

Q34576427-1cc3e39f-a48b-4462-8937-44215b0d8f8d

P356

P1433

Neuropsychopharmacology

P1476

Dopamine transporter 3'-UTR VN ...... tic study with methylphenidate

@en

P2093

Adam Torkaman-Zehi

http://www.w3.org/2001/XMLSchema#string

Ferid Fathalli

http://www.w3.org/2001/XMLSchema#string

George Schwartz

http://www.w3.org/2001/XMLSchema#string

Leila Ben Amor

http://www.w3.org/2001/XMLSchema#string

Marina Ter Stepanian

http://www.w3.org/2001/XMLSchema#string

Natalie Grizenko

http://www.w3.org/2001/XMLSchema#string

Philippe Lageix

http://www.w3.org/2001/XMLSchema#string

Ridha Joober

http://www.w3.org/2001/XMLSchema#string

Sarojini Sengupta

http://www.w3.org/2001/XMLSchema#string

Sherif Karama

http://www.w3.org/2001/XMLSchema#string

P2860

Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder

Evidence for linkage disequilibrium between the dopamine transporter and bipolar disorder.

Stimulant effects in attention deficit hyperactivity disorder: theoretical and empirical issues.

Psychiatric pharmacogenetics: personalizing psychostimulant therapy in attention-deficit/hyperactivity disorder.

A bias-ed assessment of the use of SNPs in human complex traits.

Attention-deficit/hyperactivity disorder pharmacogenomics.

Correspondence of parent and teacher reports in medication trials.

The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans.

The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression.

Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder.

P2888

P304

1370-1376

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.NPP.1301240

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P50

Norbert Schmitz

P577

2006-10-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6733245

http://www.w3.org/2001/XMLSchema#string

P6179

1018138268

http://www.w3.org/2001/XMLSchema#string

P698

17063150

http://www.w3.org/2001/XMLSchema#string

P921